![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
C-EDGE: INTEGRATED ANALYSIS FROM THE PHASE 2/3 STUDIES OF ELBASVIR / GRAZOPREVIR IN PATIENTS WITH HCV/HIV (2)
|
|
|
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
Nelson, M, Rockstroh J, Mallolas J, Katlama C, Nahass R, Saag M, Sulkowski M, Howe A, Hwang P, Nguyen B-Y, Wahl J, Barr E, Robertson M, Haber B, Platt H.
![IDSA1.gif](../images/101915/101915-8/IDSA1.gif)
![IDSA2.gif](../images/101915/101915-8/IDSA2.gif)
![IDSA3.gif](../images/101915/101915-8/IDSA3.gif)
![IDSA4.gif](../images/101915/101915-8/IDSA4.gif)
![IDSA5.gif](../images/101915/101915-8/IDSA5.gif)
![IDSA6.gif](../images/101915/101915-8/IDSA6.gif)
![IDSA7.gif](../images/101915/101915-8/IDSA7.gif)
![IDSA8.gif](../images/101915/101915-8/IDSA8.gif)
![IDSA9.gif](../images/101915/101915-8/IDSA9.gif)
![IDSA10.gif](../images/101915/101915-8/IDSA10.gif)
![IDSA11.gif](../images/101915/101915-8/IDSA11.gif)
![IDSA12.gif](../images/101915/101915-8/IDSA12.gif)
![IDSA13.gif](../images/101915/101915-8/IDSA13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|